Operation Warp Speed Shortlist Not Decided Yet, Says Novavax

We’re Still In The Running, Says R&D Chief

Novavax gained a US Department of Defense contract for its vaccine candidate recently, and is confident its nanoparticle approach provides a good alternative to other technologies.

Covid19_Blue_Vaccine

More from Business

More from Scrip